Total Number of Communication Reports: 31
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Economic Development, Health
|
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan
|
Policies or Program
|
Economic Development, Health
|
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada
|
Policies or Program
|
Health
|
Engagement with officials regarding Health Canada’s proposed development of a strategy for drugs for rare disorders and other aspects of national pharmacare, including proposals for a Canada Drug Agency and a national formulary
|
Policies or Program
|
Health
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Policies or Program, Regulation
|
Health
|
Health Canada Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements) (SOR/2019-298) published in the Canada Gazette Part 2 on August 21, 2019
|
Regulation
|
LSO is a business-led, member-funded, not-for-profit organization with a legacy of more than 25 years advancing the success of Ontario’s life sciences sector
Jason Field, President & CEO
Address:
162 Cumberland Street, Suite 310
Toronto, ON M5R 3N5
Canada
Telephone number:
647-821-3392
Life Sciences Ontario (LSO) is not a subsidiary of any other parent companies.
Life Sciences Ontario (LSO) does not have any subsidiaries that could have a direct interest in the outcome of the undertaking